Emma Mead
Interim Chief Scientific Officer for Oxford Drug Discovery Institute
Recent publications
- 
                            
    
        
            
            
                Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor
            
            
                Preprint O’Brien DP. et al, (2024) 
- 
                            
    
        
            
            
                Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation
            
            
                Journal article Mead E. et al, (2016), Journal of Alzheimer's Disease, 54, 1521 - 1538 
